TrialMedicine2018

Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses.

Andrea B V Lomonte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.